North east Scotland is home to world-class enterprises tackling modern epidemics, from neurodegenerative diseases and infectious diseases to cancer, diabetes and cardiovascular diseases. Opportunity North East Limited and ONE BioHub are partnering with The Times and Sunday Times Scotland to stage the third bi-ennial Life Sciences Summit on Wednesday, March 20, 2024 at the King’s College Conference Centre at University of Aberdeen.

Join entrepreneurs, investors, and industry leaders at the 2024 Life Sciences Summit in Aberdeen, where experts will explore what it takes to transform the first spark of an idea into a commercial reality. Hear from investors who support companies at every stage of the development pipeline, including the CEO of Innovate UK, Indro Mukerjee, and senior representatives from LifeArc Ventures, Deepbridge Capital, Epidarex and Archangel Investors.

The North-East of Scotland is home to a distinct cluster of clinical-stage biotech companies and, with the recent opening of the ONE BioHub innovation hub, is a region poised to maximise its life sciences sector’s health, wellbeing, and economic potential. Join the summit to learn from the Scottish entrepreneurs behind biotech, medtech and healthtech companies, including NovaBiotics, Elasmogen, TauRx and EpitogenX. Explore cutting-edge approaches to drug discovery with artificial intelligence experts and discuss the future of life sciences with leading industry commentators, including the BioIndustry Association.

Join Times science editor Tom Whipple, Times columnist Gillian Bowditch, and life sciences leaders as they explore the exciting potential of this dynamic, innovative and fast growing sector.

Further details available at: https://www.opportunitynortheast.com/events/times-and-sunday-times-life-sciences-summit